Advanced Oncotherapy PLC (LSE:AVO) - Share price - Overview

Stock Report

Advanced Oncotherapy PLC AVO

Last Price
GBX14.50

Day Change
-0.75|-4.92%

As of 27/06/2017
15:33:54 BST | GBX
Minimum 15 Minutes Delay.

Last Close15.25p
Day Range14.00 - 15.75
Mkt Cap11.50Mil
52-Wk Range13.50 - 175.00
Yield %-
ISINGB00BD6SX109
Volume230,855
P/E-0.41
P/SInfinity
P/CF-0.66

Share Price

Financials
201320142015
More ...
Income Statement
Revenue0.070.110.00
Operating Income-3.17-6.45-8.51
Net Income-3.94-7.46-6.56
Basic EPS-0.25-0.22-0.13
Avg. Diluted Shares Outstanding163451
Balance Sheet
Current Assets1.383.1716.68
Non Current Assets9.3711.3014.06
Total Assets10.7514.4730.74
Current Liabilities5.393.333.46
Total Liabilities5.393.333.46
Total Equity5.3711.1327.28
Cash Flow
Operating Cash Flow-2.94-6.56-9.84
Capital Expenditure-0.73-1.31-4.29
Free Cash Flow-3.67-7.87-14.13

In millions, except "Basic EPS". Currency is GBP.

Company Profile

Advanced Oncotherapy PLC is engaged in providing radiotherapy systems for cancer treatment through the use of a novel proton therapy technology.

Sector

Healthcare

Industry

Medical Devices

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

51
Key Stats
More ...
Price/Earning TTM-2.84
Price/Book0.55
Price/Sales TTMInfinity
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-Infinity
Net Margin % TTM-Infinity
ROE TTM-34.13
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.